Novo Nordisk
NVO
NVO
1,365 hedge funds and large institutions have $16.6B invested in Novo Nordisk in 2025 Q3 according to their latest regulatory filings, with 159 funds opening new positions, 489 increasing their positions, 537 reducing their positions, and 220 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
28% less first-time investments, than exits
New positions opened: 159 | Existing positions closed: 220
31% less call options, than puts
Call options by funds: $2.04B | Put options by funds: $2.98B
33% less funds holding in top 10
Funds holding in top 10: 24 → 16 (-8)
Holders
1,365
Holding in Top 10
16
Calls
$2.04B
Puts
$2.98B
Top Buyers
| 1 | +$758M | |
| 2 | +$338M | |
| 3 | +$310M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$199M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$152M |
Top Sellers
| 1 | -$980M | |
| 2 | -$407M | |
| 3 | -$343M | |
| 4 |
Fayez Sarofim & Co
Houston,
Texas
|
-$175M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$145M |
